Pulmonary arterial hypertension is caused by narrowing of the blood vessels in the lungs. Learn how it happens, including ...

Main pulmonary artery diameter is a prognostic indicator in patients with pulmonary arterial hypertension without congenital heart disease.

CHICAGO -- Adding sotatercept (Winrevair) to the treatment regimen for pulmonary arterial hypertension (PAH) in high-risk ...

A small, multi-country analysis of women of child-rearing age has found that these patients experience limits on activities ...

A larger diameter of the main pulmonary artery predicts poorer outcomes in pulmonary arterial hypertension (PAH) patients, a study found.

If you have pulmonary hypertension, it means you have high blood pressure in your pulmonary arteries, the blood vessels that carry blood from the right side of your heart through your lungs.

It may be one of the main causes of high blood pressure ... that may contribute to and predict the development of pulmonary arterial hypertension (PAH). A new study revealed that people who ...

Strong positive interim data from an earlier Phase 3 trial has led to early cessation of Merck’s pulmonary arterial ...

Highlight box Key findings • The bibliometric analysis summarized the major areas and promising research directions on chronic thromboembolic pulmonary hypertension (CTEPH) over the past two decades.

A new program in the Central Valley is now offering much-needed treatments for patients suffering from an advanced form of lung disease called pulmonary ...